Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. The company operates through Pharmaceutical Manufacturing, Pharmaceutical Distribution, Medical Aesthetics, and Industrial Microbiology segments. It offers Chinese medicine, immunosuppressive agents, endocrine, digestive system, antineoplastic, cardiovascular, antibiotic drugs, medical beauty field, and medical devices, as well as engages in pharmaceutical logistics and industrial microbiology activities. In addition, the company provides formulation filling, technical, transportation and warehousing services. The company has strategic collaboration with Heidelberg Pharma AG to jointly develop Antibody Drug Conjugates (ADCs). Huadong Medicine Co., Ltd was incorporated in 1993 and is headquartered in Hangzhou, China.
Research context
Huadong Medicine Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Huadong Medicine Co., Ltd is currently in a long term uptrend where the price is trading 18.9% above its 200 day moving average.
From a valuation standpoint, the stock is 79.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.0.
Huadong Medicine Co., Ltd's total revenue sank by 5.7% to $9B since the same quarter in the previous year.
Its net income has increased by 7.0% to $660M since the same quarter in the previous year.
Finally, its free cash flow grew by 192.1% to $304M since the same quarter in the previous year.
Based on the above factors, Huadong Medicine Co., Ltd gets an overall score of 4/5.